Diagnosis and management of hyperlipidaemia

Area of Science:

• Cardiology
• Metabolic Disorders
• Genetics

Background:

• Hyperlipidaemia is a primary risk factor for coronary heart disease.
• It significantly contributes to atheroma progression.
• Effective management is crucial for cardiovascular risk reduction.

Purpose of the Study:

• To review strategies for reducing cardiovascular risk in hyperlipidaemia patients.
• To address the identification and management of polygenic and monogenic lipid disorders.
• To cover treatment approaches with or without established cardiovascular disease.

Main Methods:

• Literature review of current guidelines and research.
• Analysis of diagnostic criteria for lipid disorders.
• Synthesis of therapeutic strategies for hyperlipidaemia.

Main Results:

• Comprehensive strategies are essential for managing hyperlipidaemia.
• Identification and tailored treatment of genetic lipid disorders are key.
• Risk reduction requires addressing lipid profiles in diverse patient populations.

Conclusions:

• Integrated management of hyperlipidaemia is vital for preventing cardiovascular events.
• Personalized treatment approaches for genetic lipid disorders improve outcomes.
• Proactive cardiovascular risk management in hyperlipidaemia is paramount.